share_log

AnPac Bio-Medical Science In Dec 2022 & Jan 2023, Signed Definitive Investment Agreements With Several Third Party Investors; Investors Agreed To Purchase 29.7M Newly Issued Class A Ordinary Shares Of Co At A Price Of $0.175/Share

AnPac Bio-Medical Science In Dec 2022 & Jan 2023, Signed Definitive Investment Agreements With Several Third Party Investors; Investors Agreed To Purchase 29.7M Newly Issued Class A Ordinary Shares Of Co At A Price Of $0.175/Share

安派生物醫學科技於 2022 年 12 月及 2023 年 1 月,與多位第三方投資者簽訂確定投資協議;投資者同意以 0.175 美元/股的價格購買 29.7 萬股新發行的 A 類普通股
Benzinga Real-time News ·  2023/01/24 07:27

AnPac Bio-Medical Science In Dec 2022 & Jan 2023, Signed Definitive Investment Agreements With Several Third Party Investors; Investors Agreed To Purchase 29.7M Newly Issued Class A Ordinary Shares Of Co At A Price Of $0.175/Share

安派生物醫學科技於 2022 年 12 月及 2023 年 1 月,與多位第三方投資者簽訂確定投資協議;投資者同意以 0.175 美元/股的價格購買 29.7 萬股新發行的 A 類普通股

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論